ADOC
NASDAQEdoc Acquisition Corp.
Edoc Acquisition Corp. (ADOC) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for ADOC in the last 30 days. The most recent was published Apr 1, 2024.
Latest news
25 items- SECSEC Form 15-12G filed by Edoc Acquisition Corp.15-12G - Edoc Acquisition Corp. (0001824884) (Filer)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- SECSEC Form 25-NSE filed by Edoc Acquisition Corp.25-NSE - Edoc Acquisition Corp. (0001824884) (Subject)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- SECSEC Form 425 filed by Edoc Acquisition Corp.425 - Edoc Acquisition Corp. (0001824884) (Subject)
- SECSEC Form 425 filed by Edoc Acquisition Corp.425 - Edoc Acquisition Corp. (0001824884) (Subject)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- NEWSEdoc Acquisition Corp. Announces Postponement Of Special Meeting Of Shareholders On Proposed Business Combination
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- SECSEC Form 425 filed by Edoc Acquisition Corp.425 - Edoc Acquisition Corp. (0001824884) (Subject)
- PREdoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business CombinationVictor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC
- PREdoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business CombinationVictor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LL
- 13D/GSEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)
- SECSEC Form 425 filed by Edoc Acquisition Corp.425 - Edoc Acquisition Corp. (0001824884) (Subject)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- 13D/GSEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)
- PRAustralian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business CombinationScheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, Australian Oilseeds Investments Pty Ltd. is Expected to Trade on Nasdaq Under the Ticker "COOT" ~ Victor, NY and Cootamundra New South Wales, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Australian Oilseeds" or "Pubco") and EDOC Acquisition Corp., a publicly-traded special purpose acquisition company ("EDOC") (NASDAQ:ADOC, ADOCW, ADOCR))), today announced that the Securities and Exchange Commission ("SEC")
- 13D/GSEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)
- SECSEC Form 425 filed by Edoc Acquisition Corp.425 - Edoc Acquisition Corp. (0001824884) (Subject)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- NEWSEdoc Acquisition Reports Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
- PREdoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QVictor, NY, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (NASDAQ: ADOC) (the "Company") announced that it received a letter from The Nasdaq Capital Market ("Nasdaq") on November 30, 2023 indicating that (i) the Company's failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the "Form 10-Q"), in violation of the Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule"), serves as an additional basis for delisting the Company's securities from Nasdaq based on Listing Rule 5810(b) and (ii) the Nasdaq Hearings Panel (the "Panel") will consider this additional deficiency in its decision regarding the Company's cont
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
- SECSEC Form 10-Q filed by Edoc Acquisition Corp.10-Q - Edoc Acquisition Corp. (0001824884) (Filer)
- SECEdoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Edoc Acquisition Corp. (0001824884) (Filer)
ADOC FAQ
7 questionsWhat does Edoc Acquisition Corp. do?
Edoc Acquisition Corp. is a blank check company. The company intends to focus on businesses primarily operating in the health care and health care provider space in North America and the Asia-Pacific. Edoc Acquisition Corp. was incorporated in 2020 and is based in Victor, New York.What is the latest news on ADOC?
Quantisnow has not tracked any new filings, ratings or press releases for ADOC in the last 30 days. The most recent wire item was published on April 1, 2024.Where does ADOC stock trade?
Edoc Acquisition Corp. (ADOC) is listed on NASDAQ.What sector and industry is ADOC in?
Edoc Acquisition Corp. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Edoc Acquisition Corp. go public?
Edoc Acquisition Corp. (ADOC) completed its IPO in 2020.What companies are similar to ADOC?
Notable peers in the same industry include EXEL (Exelixis Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), AMGN (Amgen Inc.), RVMD (Revolution Medicines Inc.). Compare ADOC side-by-side with any of them on Quantisnow.How can I track ADOC on Quantisnow?
Quantisnow aggregates Edoc Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ADOC to receive live email and push alerts on every new disclosure.